2BB score and signals
Janux Therapeutics, Inc.’s current 2BB score is 56 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 54 | Moderate |
| Momentum | 29 | Weakening |
| Financial strength | 45 | Normal |
| Quality | 100 | Very Strong |
| Risk | 39 | Low |
Company facts
| Founded | 2017 |
| Employees | 113 |
| 52-week range | $12.12 – $35.25 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.5442 | — | $7.16M |
| 2026-11-04 | — | -0.4841 | — | $7.90M |
| 2026-08-11 | — | -0.392 | — | $16.82M |
| 2026-05-07 | -0.39 | -0.5369 | $3.73M | $3.91M |
Related companies
2BBBullish & Bearish